Successful partnerships are the result of a synergistic relationship between two groups with the same vision. Norgenix believes in synergistic partnerships.
As a strategic partner, Norgenix and its related JM Smith Corporation companies can provide strategic direction and capitalization to build success.
Companies that partner with Norgenix benefit from the application of an innovative business model proven to accelerate market entrance for novel products. Click here to see the Norgenix advantage.
Norgenix is seeking to collaborate with U.S. companies that have:
- Products in late-stage development
- Products pending approval (NDA, ANDA, 505b2, and OTC)
- Novel medical device technology
- Existing market-ready products
- Products ready for re-launch or products that have been shelved
Norgenix is also seeking to establish strategic alliances with global companies interested in commercializing products in the U.S. These companies benefit from an established infrastructure, which can expedite market entrance.